Relative to the use of nasal spray to treat anaphylaxis.

This bill aims to allow the use of nasal spray as a treatment option for anaphylaxis, a severe allergic reaction. The bill seeks to expand treatment options available to individuals suffering from anaphylaxis by including nasal sprays as an alternative to traditional injections.

The bill would primarily impact individuals who experience anaphylaxis, their caregivers, and healthcare providers. By making nasal sprays a recognized treatment, it could offer a less invasive and potentially more convenient option for managing anaphylactic reactions.

Currently, the bill has moved through several stages in the legislative process. It was introduced, referred to relevant committees, and has passed through committee reports with amendments. As of May 2025, the bill is pending a motion committee amendment in the Senate, and a vote is expected soon. The bill has already passed through the House with amendments and awaits further action in the Senate.